Fig. 1 (Structural Formula of Prandin)
Prandin
Product Images NDC 68151-3565
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Prandin (NDC 68151-3565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fig. 2 (Prandin Pioglitazone Combination Study)
Label Image (Lbl681513565)
Prandin is a prescription medication containing repaglinide, which is used to treat high blood sugar in people with type 2 diabetes. It is manufactured by Novo Nordisk and the specific container lot number is A108739. The medication comes in the form of a 0.5 mg tablet and the expiration date is 08/14. The rest of the text is not readable.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
